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Ca2+-binding protein 2 (CaBP2) inhibits the inactivation of heterolo-
gously expressed voltage-gated Ca2+ channels of type 1.3 (CaV1.3)
and is defective in human autosomal-recessive deafness 93
(DFNB93). Here, we report a newly identified mutation in CABP2 that
causes a moderate hearing impairment likely via nonsense-mediated
decay of CABP2-mRNA. To study the mechanism of hearing impair-
ment resulting from CABP2 loss of function, we disrupted Cabp2 in
mice (Cabp2LacZ/LacZ). CaBP2 was expressed by cochlear hair cells,
preferentially in inner hair cells (IHCs), and was lacking from the
postsynaptic spiral ganglion neurons (SGNs). Cabp2LacZ/LacZ mice dis-
played intact cochlear amplification but impaired auditory brainstem
responses. Patch-clamp recordings from Cabp2LacZ/LacZ IHCs revealed
enhanced Ca2+-channel inactivation. The voltage dependence of
activation and the number of Ca2+ channels appeared normal in
Cabp2LacZ/LacZ mice, as were ribbon synapse counts. Recordings
from single SGNs showed reduced spontaneous and sound-evoked
firing rates. We propose that CaBP2 inhibits CaV1.3 Ca
2+-channel
inactivation, and thus sustains the availability of CaV1.3 Ca
2+ channels
for synaptic sound encoding. Therefore, we conclude that human
deafness DFNB93 is an auditory synaptopathy.
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Hearing relies on faithful transmission of information at rib-bon synapses between inner hair cells (IHCs) and spiral
ganglion neurons (SGNs; recently reviewed in refs. 1, 2). Ca2+
channels at the IHC presynaptic active zone are key signaling
elements because they couple the sound-evoked IHC receptor
potential to the release of glutamate. IHC Ca2+-channel complexes
are known to contain CaV1.3 α1 subunit (Cav1.3α1) (3–5), beta-
subunit 2 (CaVβ2) (6), and alpha2–delta subunit 2 (α2δ2) (7) to
activate at around −60 mV (8–10), and are partially activated
already at the IHC resting potential in vivo [thought to be between
−55 and −45 mV (11, 12)], thereby mediating “spontaneous”
glutamate release during silence (13).
Compared with CaV1.3 channels studied in heterologous ex-
pression systems, CaV1.3 channels in IHCs show little inactivation,
which has been attributed to inhibition of calmodulin-mediated
Ca2+-dependent inactivation (CDI) (14–17) by Ca2+-binding
proteins (CaBPs) (18, 19) and/or the interaction of the distal and
proximal regulatory domains of the CaV1.3α1 C terminus (20–22).
This “noninactivating” phenotype of IHC CaV1.3 enables reliable
excitation-secretion coupling during ongoing stimulation (23–
25). In fact, postsynaptic spike rate adaptation during ongoing
sound stimulation is thought to reflect primarily presynaptic
vesicle pool depletion, with minor contributions of CaV1.3 in-
activation or AMPA-receptor desensitization (23–26). CaBPs
are calmodulin-like proteins that use three functional out of
four helix–loop–helix domains (EF-hand) for Ca2+ binding (27).
They are thought to function primarily as signaling proteins (28)
and differentially modulate calmodulin effectors (29, 30). In
addition, CaBPs might also contribute in buffering free cytoso-
loic Ca2+ ions, as do other small EF-hand calcium-binding pro-
teins, such as calretinin, calbindin–D-28k, and parvalbumin-α
(31–33). The relevance of the individual CaBPs expressed in IHCs
[CaBP1, CaBP2, CaBP4, and CaBP5 (18, 19, 34)] for inhibiting
CDI and for hearing is not understood well. Genetic disruption
of Cabp4 in mice caused a very modest increase in CDI of IHC
Ca2+ influx and left hearing intact (18).
Recently, a mutation in the CABP2 gene was shown to cause
recessive sensorineural hearing impairment [DFNB93 (35)].
Specifically, this splice site mutation in CABP2 is thought to
cause a frameshift resulting in a premature truncation of a
CaBP2 amino acid sequence lacking the C-terminal EF hands 3
and 4. The truncated CaBP2 less potently inhibited CaV1.3 in-
activation when studied in HEK293-T cells. This observation
suggested that enhanced inactivation of CaV1.3 channels might
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contribute to the hearing impairment DFNB93. Moreover,
DFNB93 might arise from impaired excitation-secretion cou-
pling due to a depolarized shift of Ca2+-channel activation as was
postulated for CABP4 disruption in photoreceptors in congenital
stationary night blindness (36). Finally, CaBP2 reduced the Ca2+
-current density in HEK293-T cells, which was not found with
the truncated CaBP2 reported to cause DFNB93 (35). There-
fore, excess Ca2+ influx and glutamate release might cause
excitotoxic synapse loss [excitotoxicity during loud noise (37)]
in DFNB93.
Here, we describe an unreported human CABP2 loss-of-function
mutation and analyze auditory function of a newly generated
Cabp2-deficient mouse line at the synaptic, cellular, and systems
levels. Lack of Cabp2 enhanced inactivation of Ca2+ influx in IHCs,
whereas its amplitude and voltage dependence of activation were
normal. Cabp2 deficiency caused reduced and more jittered ac-
tion potential firing in SGNs and impaired auditory brainstem
responses (ABRs) despite intact cochlear amplification. This
observation indicates that a synaptic hearing impairment
underlies DFNB93.
Results
A Newly Identified Loss-of-Function Mutation in CABP2 Causes
Recessive Hearing Loss. The family (pedigree is shown in Fig.
1A) of the affected subjects [a 16-y-old male subject (III:1) and
his 11-y-old sister (III:3)] originated from Northern Italy. For the
clinical and genetic studies, both parents were also enrolled and
all subjects underwent full clinical examinations, excluding syn-
dromic features. Apart from presbyacusis in subjects I:1 and I:4,
there was no history of hearing defects in the family. Pedigree
reconstruction indicated a common ancestor of the subjects’ par-
ents (II:2 and II:5) in the first half of the 19th century. Both
affected subjects presented prelingual hearing impairment af-
fecting their communication. Tympanometry indicated normal mid-
dle ear function. Pure-tone air conduction audiometry revealed
symmetrical moderate-to-severe hearing impairment across all
frequencies, preferentially affecting the middle-frequency range
(“U shape”; Fig. 1C). This feature led to screening for mutations
in the TECTA and CABP2 genes, which are known to cause an
audiometric phenotype similar the one observed in the subjects
(35, 38).
PCR amplification of all seven CABP2 exons, followed by bi-
directional Sanger capillary sequencing, allowed us to identify a
homozygous G-to-T transversion at nucleotide 466 in exon 5
(c.466G > T) in the DNA of subject III:1 (Fig. 1B, Top). The
mutation creates a premature stop codon (TAG), likely resulting
in a loss of function due to nonsense-mediated mRNA decay
(schematic is shown in Fig. 1D). The same CABP2 c.466G > T
mutation was found in the homozygous state in the proband’s
sister (III:3), whereas both parents (II:2 and II:5), the younger
unaffected child (III:4), and three other family members (I:1, I:4,
and II:4) were carriers of a single copy of the mutated allele (Fig.
1B, Middle). The presence of the c.466G > T variant was ex-
cluded from a sample of 225 control white subjects by restriction
analysis of a PCR amplicon encompassing the mutant nucleotide
(Fig. 1B, Bottom). Moreover, there was no G > T sequence
variant reported at position 466 in the database of the Exome
Aggregation Consortium (exac.broadinstitute.org/). In the four
children and their parents, the chromosomal region encompassing
the CABP2 c.466G > T locus was also genotyped for four
microsatellites (D11S1765, D11S913, D11S1889, and D11S1337)
and four single-nucleotide polymorphisms (rs2256154, rs630172,
rs1695, and rs1531514) by capillary electrophoresis of fluo-
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Fig. 1. A previously unidentified mutation in CABP2 causes moderate-to-severe hearing impairment. (A) Pedigree and segregation of the c.466G > T (p.E156X)
mutation in a family with hearing-impaired children. Dates of birth (b.) of the common ancestors were ascertained from historical marriage registers and are reported
under their symbols. (B) Genotyping of test subjects revealed a nonsense mutation in CABP2: results of sequencing CABP2 exon-5 c.460–474 in the proband (subject
III:1; Top), his father (subject II:2;Middle), and one of his unaffected brothers (subject III:2; Bottom). Nomenclature is based on NM 016366.2 and NP 057450.2. The
mutated nucleotide is highlighted in magenta. Codon 156 is the last one indicated. (C) Binaural mean air conduction thresholds of the proband (subject III:1;
circles) and his sister (subject III:3; squares). Hearing loss is symmetrical and more pronounced in the middle frequencies. (D) Schematic description of CABP2,
consisting of seven exons, with the c.466G > T mutation indicated by the black arrow. Amutation in exon 5 is predicted to lead to nonsense-mediated decay (NMD).
(E) Shared haplotype (7.35 Mb) encompassing the c.466G > T transversion in the mutation-bearing paternal and maternal alleles inherited by the children.
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products, respectively. Mutation-bearing chromosomes shared a
common haplotype (Fig. 1E), thus confirming that the patho-
genic variant is identical by descent in both parents and has been
inherited from a common ancestor, as suggested by pedigree
reconstruction.
In conclusion, we identified a mutation in CABP2 (c.466G > T)
that causes a recessive nonsyndromic hearing impairment similar
to what we previously described for a splice site mutation in
CABP2, which is thought to truncate the CaBP2 amino acid
sequence. We postulate that both alleles disrupt CaBP2 function
and assume that the c.466G > T mutation compromises CaBP2
function via nonsense-mediated mRNA decay. The tone audio-
grams were comparable between both mutant CABP2 genotypes
(35). However, unlike in our previous report, a transitory evoked
otoacoustic emission (TEOAE) was observed in subject III:1 in
the course of clinical examination at the age of 4 y (subject III:3
was not tested for TEOAE). This finding suggests that, at least
initially, the CABP2 mutation spared cochlear amplification by
outer hair cells (OHCs) and might arise at the level of IHCs in
their ribbon synapses or the SGNs. To elucidate the disease
mechanism further and study the role of CaBP2 in hearing, we
turned to analysis in mice.
Cabp2 Is Expressed in Inner Ear Hair Cells and Is Required for Normal
Hearing in Mice. We generated a DFNB93 mouse model by using
mouse ES cells of the Knockout Mouse Project (KOMP) reposi-
tory (CSD50029, DEPD0003_7_F06) that contain an IRES:LacZ
trapping cassette in the locus of the Cabp2 gene, followed by loxP-
flanked exons 3 and 4 for Flp- and Cre-mediated conditional
deletion (Fig. 2A). We derived constitutive Cabp2LacZ/LacZ mu-
tants with globally defective Cabp2 function by crossing mice
carrying the floxed Cabp2 allele with a Cre-driver line that ex-
presses Cre-recombinase under the promoter of the transcription
factor EIIa (39). Cabp2LacZ/LacZ mice were born at Mendelian
ratio and were viable and fertile.
First, we studied the expression of Cabp2 using RT-PCR of the
cochlea and LacZ staining of various nervous tissues. Within the
cochlea, mRNA for the long Cabp2 isoform was detected in wild-
type mice and Cabp2 mRNA was absent in Cabp2LacZ/LacZ mice
(Fig. 2B). The LacZ signal was restricted to hair cells, with a much
stronger staining in IHCs than in OHCs (Fig. 2 C and C′). In ad-
dition, we found LacZ signal in vestibular hair cells (Fig. 2C′′) and
in some cells in the outer retina, potentially representing horizontal
cells (Fig. 2C′′′) because they were positive for calbindin–D-28k
(Fig. S1C). Sagittal sections of the whole brain appeared to lack
LacZ staining (data not shown). Efforts to immunolocalize Cabp2
in IHCs failed with commercially available and newly generated
antibodies using various protocols, which resulted in either unspe-
cific staining or lack of staining (data not shown).
Next, we performed recordings of ABRs (reflecting neuronal
activity along the early auditory pathway) and of otoacoustic
emissions for a first characterization of hearing in Cabp2LacZ/LacZ
mice. ABR amplitudes were reduced (Fig. 3A) and ABR
thresholds were elevated in the frequency range of 6–24 kHz
(Fig. 3B) in 8-wk-old Cabp2LacZ/LacZ mice of either sex. Het-
erozygous mice showed normal ABRs (Fig. S1D) consistent with
the autosomal recessive phenotype observed for human CABP2
mutations. The thresholds and amplitudes of distortion product
otoacoustic emissions (DPOAEs) were comparable between
Cabp2LacZ/LacZ mutants and their littermate controls (Fig. 3 C
and D). We probed retinal processing by scotopic electroreti-
nography (ERG), which appeared intact in Cabp2LacZ/LacZ mice
(ERGs were not tested at photopic conditions). In summary,
within the ear, Cabp2 is expressed in IHCs, OHCs, and vestibular
hair cells but not in cochlear spiral ganglion neurons. Based
on this expression pattern and our recordings of ABRs and
DPOAEs, we hypothesize that the impairment of auditory pro-
cessing occurs downstream of hair cell mechanoelectrical trans-
duction and OHC amplification, most likely at the IHC synapses,
a condition also known as auditory synaptopathy (40).
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Fig. 2. Cabp2 is expressed in hair cells of the inner ear and in the retina. (A) Schematic of IRES:LacZ Cabp2 trapping cassette with loxP sites flanking the neomycin resistance
and exons 3 and 4ofCabp2. Exon 2 is not expressed in the short Cabp2 isoform. EIIa-cre recombination induces the removal of the neomycin cassette and critical exons, resulting
in a LacZ-tagged null allele. RT-PCR primer (Table S1) annealing sequences are shown by gray arrows and are provided with the respective PCR number (Nr.) they were used
for. (B) RT-PCR of the apical turn of the organ of Corti comparing Cabp2 mRNA expression in Cabp2+/+ and Cabp2LacZ/LacZmice, respectively. Primer annealing regions
are located in exon 1 and exon 5 (PCR1, positive in Cabp2+/+) or in the LacZ sequence and exon 5 (PCR2: negative upon Cabp2 deletion). In Cabp2+/+, one band at 418
base pairs (bp) was identified, confirming the expression of the long-CaBP2 isoform in the organ of Corti. The absence of a band in PCR1 and PCR2 of Cabp2LacZ/LacZ
tissue confirms the truncation of Cabp2 (n = 3 animals). GAPDH was used as a positive control (PC; 572 bp) mut, Cabp2LacZ/LacZ; nc, negative control (water). (C)
β-Galactosidase staining of the cochlea, utricle, and retina of Cabp2LacZ/LacZ mice is shown. IHCs, OHCs (C and C′) and vestibular hair cells (C′′) were LacZ-positive.
(Scale bars: C′, 20 μm; C′′, 500 μm.) (C′′′) In retinal slices, the LacZ signal was detected in the inner nuclear layer. (Scale bar: 20 μm.)














Cabp2 Disruption Does Not Alter the Number and Gross Molecular
Anatomy of IHCs and Their Afferent Synapses. We studied the
number and gross morphology of IHCs and their afferent synapses
using confocal microscopy of immunolabeled organs of Corti.
Using parvalbumin-α or Ctbp2/RIBEYE as a hair cell marker, we
did not find an obvious IHC loss in Cabp2LacZ/LacZmice at the age
of 2–3 and 8 wk (Fig. S2). The development of IHCs appeared
unaffected, as tested by staining of small- and large-conductance
Ca2+-activated K+ channels (SK and BK, respectively) after the
onset of hearing (Fig. S2 A and B). As expected for normal post-
natal IHC maturation, BK channels were located at the neck region
of IHCs and SK2 puncta were absent in IHCs (but present in
OHCs) of Cabp2LacZ/LacZ mice at postnatal day 15 (P15; Fig. S2B).
The number of ribbon-occupied synapses, identified as juxta-
posed spots of CtBP2/RIBEYE (marking the presynaptic ribbon)
and GluA2/3 (marking the postsynaptic glutamate receptor clus-
ters) immunofluorescence (41), as well as the total number
of synapses (GluA2/3 spots), were indistinguishable between
Cabp2LacZ/LacZ mutants and littermate controls at 3 and 8 wk of
age (Fig. S2 C–E). This observation rules out the possibility that
DFNB93 was caused by a loss of IHCs or their synapses (e.g.,
due to degeneration or glutamate excitotoxicity). Moreover,
immunolabeling for CaV1.3 and CtBP2/RIBEYE indicated
normal synaptic clustering of IHC Ca2+ channels in 8-wk-old
Cabp2LacZ/LacZ mutants (Fig. S2F). In summary, Cabp2 disruption
does not affect the maturation, number, or gross molecular anat-
omy of IHCs and their afferent synapses.
Disruption of Cabp2 Causes Enhanced Ca2+-Current Inactivation.
Next, we revisited the regulation of IHC-like CaV1.3 channels
by CABP2 in HEK293 cells using a refined approach [corrected
CaV1.3α clone (22) and improved cell viability by coexpression of
a Ca2+-activated K+ channel (SK3-1) limiting Ca2+ influx at the
resting potential]. We found comparable maximal current densities
[Ca2+ currents normalized to the cell capacitance in picoampere
per picofarad (pA/pF)] in the presence or absence of CABP2 [Fig.
S3A; −87.47 ± 20.04 pA/pF with CABP2 vs. −57.45 ± 12.09 pA/pF
without CABP2 (control); P > 0.05, Wilcoxon rank sum test]. This
observation contrasts with our previous report of a reduction in
current density when coexpressing CABP2 in HEK293-T cells (35),
which might reflect a selection bias related to cell viability issues
due to the noninactivating Ca2+ influx in the absence of a negative
feedback. Moreover, we observed that CABP2 shifted the voltage
dependence of CaV1.3 activation to more hyperpolarized poten-
tials [Fig. S3B; potential of half-activation (V0.5) of −35.4 ± 1.5 mV
compared with CaV1.3 alone: −20.8 ± 1.1; P < 0.001, Student’s
t test] as previously reported for CaV1.4 (36). This observation
primarily reflected an increased voltage sensitivity, because the
slope factor of the activation function (kact) was significantly
smaller when coexpressing CABP2 (Fig. S3B; P < 0.005, Student’s
t test). Under these recording conditions, we confirmed the po-
tency of CABP2 to inhibit CaV1.3 Ca
2+-current inactivation (35)
(Fig. S3 C–E).
Next, we performed perforated-patch recordings of whole-cell
Ca2+ currents in IHCs of Cabp2LacZ/LacZ mice to address our two
key hypotheses on Cabp2 function in regulating IHC Ca2+ cur-
rent: (i) hyperpolarized shift of Ca2+-channel activation out of
the physiological range of receptor potentials (36) and (ii) inhibi-
tion of Ca2+-channel inactivation. We studied mature IHCs of the
apical coil of the cochlea at 5 wk of age. For comparison with our in
vivo experiments, we aimed to match the physiological conditions
most closely by performing perforated-patch recordings at 37 °C
and at an extracellular Ca2+ concentration ([Ca2+]e) of 1.3 mM.
Ca2+ currents of Cabp2LacZ/LacZ IHCs elicited by depolarizations
(20 ms to various potentials) were normal in amplitude, at least
when probed from a holding potential of −57 mV (Fig. 4 A and
B), which is compatible with a normal total number of Ca2+
channels.
Moreover, the voltage dependence of Ca2+ influx (Fig. 4B)
and fractional Ca2+-channel activation (Fig. 4C) were compara-
ble in IHCs with and without functional CaBP2. Both the voltage of
half-maximal Ca2+-channel activation (V0.5: −28.03 ± 0.85 mV for
Cabp2LacZ/LacZ vs. −27.72 ± 0.94 mV for Cabp2+/+; P > 0.05,
Student’s t test) and kact (7.07 ± 0.08 mV for Cabp2
LacZ/LacZ vs.
7.41 ± 0.12 mV for Cabp2+/+; P > 0.05, Student’s t test) were
statistically indistinguishable. These observations indicate that
CaBP2 regulation of CaV1.3 is dispensable for the voltage depen-
dence of IHC Ca2+ influx and argue against a deficit of excitation-
secretion coupling due to a depolarized shift of the voltage range of
CaV1.3 operation as a disease mechanism of DFNB93. Activation
(Fig. 4D) and deactivation (Fig. 4E) kinetics were unaltered in
Cabp2LacZ/LacZ IHCs (time constant of voltage-clamp of ∼160 μs,
average series resistance of 17.8 MΩ for perforated-patch record-
ings at physiological temperature).
Using long (500 ms) step depolarizations to −14 mV and
comparing residual Ca2+ currents at 500 ms (I500,Ca; Fig. 4 F and
G) or trains of brief depolarizations (10 ms to −14 mV, 5-ms
interval; Fig. 4H) we found CaV1.3 inactivation to be substantially
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Fig. 3. Synaptic hearing impairment in Cabp2LacZ/LacZ mice. (A) Grand av-
erages (lines) and SEMs (shaded areas) of ABR waveform responses to 80-dB
click stimuli at a stimulus rate of 20 Hz in Cabp2+/+ (n = 9) and Cabp2LacZ/LacZ
(n = 7) mice at P49–P63. Roman numerals on top of the ABR graph denote
the Jewett ABR waves. Note the decrease in amplitude and delay of wave I in
Cabp2-deficient mice compared with Cabp2+/+ mice. (B) Elevated ABR
thresholds in P49–P63 mice. Tone bursts are presented at a stimulus rate of
40 Hz and clicks at 20 or 100 Hz. Error bars represent SEM, and P values are
indicated with asterisks (**P < 0.01, ***P < 0.001; Holm–Sidak t test) and
20- and 100-Hz click stimuli (***P < 0.001, Holm–Sidak t test). (C) DPOAE
thresholds (defined as the interpolated f2 intensity required to elicit a
DPOAE of 10-dB SPL) for Cabp2LacZ/LacZ (seven individual traces shown in
purple, mean shown in magenta) and Cabp2+/+ (nine individuals shown in
gray, mean shown in black) mice. The dashed line indicates the maximum
loudspeaker output of 70 dB. DPOAE thresholds were comparable between
genotypes (P > 0.05, two-way ANOVA). (D) Mean DPOAE growth functions
for Cabp2LacZ/LacZ (n = 8) and Cabp2+/+ (n = 9) mice at f1 = 9.4 kHz and f2 =
11.3 kHz are shown. DPOAEs were comparable between both genotypes at the
age of 8 wk, indicating intact active cochlear amplification in Cabp2-deficient
mice (P > 0.05, two-way ANOVA). Error bars represent SEM. n.s., P > 0.05.
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(amplitude: 0.217 ± 0.027 for Cabp2LacZ/LacZ vs. 0.114 ± 0.028 for
Cabp2+/+; P < 0.05, Student’s t test) and the slower linear (slope:
0.607 ± 0.011 for Cabp2LacZ/LacZ vs. 0.257 ± 0.040 for Cabp2+/+;
P < 0.01, Student’s t test) components of CaV1.3 inactivation were
increased, whereas the time constant of the fast component was
unaltered (τinactivation: 38.3 ± 6.9 ms for Cabp2
LacZ/LacZ vs. 39.3 ±
7 ms for Cabp2+/+).
To gain further insight into the type of inactivation, we also
studied IHCs of 2- to 3-wk-old Cabp2LacZ/LacZ mice at room
temperature for easier manipulation of the preparation. We
chose midcochlear IHCs because the ABR impairment was most
evident in the range of 12–16 kHz at this age (Fig. S4 A and B).
Using long depolarizations (500 ms to −14 mV; Fig. S4C) or
trains of brief depolarizations (10 ms to −14 mV, 5-ms interval;
Fig. S4F), we observed a modest but significant increase in
CaV1.3 inactivation in Cabp2
LacZ/LacZ IHCs (I500,Ca:0.62 ± 0.03
for Cabp2LacZ/LacZ vs. 0.73 ± 0.01 for Cabp2+/+; P < 0.001,
Student’s t test). Interestingly, the enhanced CaV1.3 inactivation in
mutant IHCs primarily represented more voltage-dependent inacti-
vation (VDI), as demonstrated by residual Ba2+ currents after 500
ms (I500,Ba: 0.71 ± 0.02 for Cabp2
LacZ/LacZ vs. 0.78 ± 0.01 for
Cabp2+/+; P < 0.005, Student’s t test; Fig. S4 D and E). In addition,
there was a trend toward increased CDI, calculated as the differ-
ence between residual Ba2+ and Ca2+ currents after 500 ms, which,
however, did not reach statistical significance (P > 0.05, Wilcoxon
rank sum test; Fig. S4E). Although the data on CaV1.3 in Cabp2-
deficient IHCs and in CABP2-expressing HEK293 cells jointly
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Fig. 4. Enhanced Ca2+-current inactivation in Cabp2-deficient IHCs of 5-wk-old mice recorded in near-physiological conditions. (A) Representative
Ca2+-current traces of Cabp2+/+ (Top) and Cabp2LacZ/LacZ (Bottom) IHCs of P39 and P44 animals. (B) Comparable current–voltage (I-V) relationships of Cabp2+/+ (n = 8) and
Cabp2LacZ/LacZ (n = 11) IHCs. Traces are depicted as mean ± SEM (shaded area). Vm, membrane potential. (C) Average activation curve derived from B shows comparable
voltage dependence of activation between both genotypes (mean ± SEM). (D, Left) Experimental paradigm and representative Ca2+-current (ICa) traces of Cabp2
+/+
(Top) and Cabp2LacZ/LacZ (Bottom) IHCs overlaid by exponential fit to determine activation kinetics. (D, Right) Quantification of activation time (Tactivation) constants
showing comparable results for Cabp2LacZ/LacZ and Cabp2+/+ IHCs (Wilcoxon rank sum test). (E, Left) Experimental paradigm and representative Ca2+-current
traces of Cabp2+/+ (Top) and Cabp2LacZ/LacZ (Bottom) IHCs overlaid by an exponential fit to determine deactivation kinetics. (E, Right) Quantification of
deactivation time constants showing comparable results for Cabp2LacZ/LacZ and Cabp2+/+ IHCs (Student’s t test). n.s., no significant difference. (F) Experi-
mental paradigm and Ca2+ currents recorded from Cabp2+/+ (n = 8) and Cabp2LacZ/LacZ (n = 11) IHCs at near-physiological conditions [35–37 °C, 1.3 mM Ca2+,
holding potential (Vh) = −57 mV]. Ipeak, peak current. Traces are presented as mean ± SEM. (G) Quantification of residual Ca2+ currents at 500 ms (I500,Ca) shows
enhanced inactivation in Cabp2-deficient compared with Cabp2+/+ IHCs (***P < 0.001, Student’s t test). (H) Progression of inactivation during train stimulation
of Cabp2LacZ/LacZ (n = 14) and Cabp2+/+ (n = 14) IHCs. Note the increase of inactivation with ongoing stimulation in Cabp2LacZ/LacZ IHCs (P < 0.005, Student’s
t test). I1st, current evoked by first depolarization; In, current evoked by n’s depolarization. Throughout the article, box plots and overlaid individual data points are
presented. Box plots show the median as a horizontal line flanked by quartiles, and whiskers are presented as the 1.5-interquartile range from box edges.














vs. Fig. S3 C–E), they disagree about regulation of the voltage
dependence of Ca2+-channel activation. We conclude that the
heterologous expression system reconstitutes the regulation of
CaV1.3 by CaBP2 in IHCs only partially.
Assessing Ca2+-induced exocytosis by perforated-patch mem-
brane capacitance measurements did not reveal a reduction of
exocytosis. In fact, we observed enhanced capacitance increments
for long depolarizations (5-wk-old animals: P < 0.001 for 100 and
200 ms, Student’s t test; Fig. S5 A and B). This excess exocytosis was
prevented after the coapplication of the synthetic Ca2+ chelators
ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid
(EGTA) and 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic
acid (BAPTA) in a ruptured-patch configuration (Fig. S5C) at
concentrations (0.5 mM each) that were previously approximately
found to mimic the action of endogenous Ca2+ buffers in IHCs
(42). The excess of sustained IHC exocytosis in Cabp2-deficient
mice might indicate a contribution of CaBP2 in Ca2+ buffering at
the active zone. To test Ca2+ buffering properties of CaBP2 fur-
ther, we used isothermal titration calorimetry and identified two
Ca2+ binding sites in wild-type CaBP2 that seem compatible with
low-affinity Ca2+ buffering by CaBP2 (Fig. S6 and Table S2). Lack
of Ca2+ buffering by CaBP2 might enable wider Ca2+ spread, pro-
moting extrasynaptic exocytosis. Such a scenario has been pro-
posed as an explanation for excessive sustained exocytosis in triple
EF-hand, Ca2+-buffer KOmice (42). In summary, we found normal
activation and deactivation but increased inactivation of CaV1.3
Ca2+ currents in Cabp2-deficient IHCs.
Disruption of Cabp2 Impairs Synaptic Sound Encoding. One way to
probe synaptic release largely independent from potential
extrasynaptic exocytosis is to record the sound-evoked spiking of
single SGNs, each of which is thought to be driven by a single
active zone (42). Therefore, and to analyze how Cabp2 deficiency
affects synaptic sound encoding, we performed in vivo extracel-
lular recordings from single SGNs where they enter the co-
chlear nucleus (43). Spontaneous firing rates were reduced in
Cabp2LacZ/LacZ mice at the age of 5–8 wk (Fig. 5A; P < 0.001,
pooling littermates and C57BL/6 controls). We then studied
sound encoding by measuring SGN firing upon tone-burst stim-
ulation. We found frequency tuning and spike rate thresholds (P =
0.21, for fibers with characteristic frequencies of 6–20 kHz) to be
normal in SGNs of Cabp2LacZ/LacZ mice (Fig. S7 A and B). This
observation corroborates our notion of normal cochlear amplifi-
cation (DPOAE; Fig. 3 C and D). We recorded rate-level func-
tions [firing rate vs. sound pressure level (SPL)] in response to
tone bursts of different SPLs at the characteristic frequency
(50 ms, applied at 5 Hz; Fig. S7C). Neither the dynamic range of
encoding nor the steepness of the rate-level functions was al-
tered in Cabp2LacZ/LacZ SGNs (Fig. S7 D and E). However, when














































































Fig. 5. Cabp2 is required for normal spontaneous and sound-evoked firing of SGNs. (A) Cumulative plot of spontaneous firing rates of SGNs recorded from
Cabp2LacZ/LacZ (n = 36) and Cabp2+/+ SGNs (n = 161, pooling littermate controls and C57Bl6 controls). Note the higher fraction of low spontaneous rate fibers in
Cabp2LacZ/LacZ mice (P < 0.001, Kolmogorov–Smirnov test). (B) Peak-aligned grand averages of poststimulus time histograms of SGNs (bin width = 0.5 ms)
recorded in response to 200 50-ms tone bursts. The time course of adaptation of Cabp2LacZ/LacZ SGNs (n = 30) is comparable to Cabp2+/+ SGNs (n = 112, pooling
littermates and C57Bl6 controls). *P < 0.05, ***P < 0.005. (C) Summary of first-spike latencies of SGNs (scattered against steady-state firing rate) showing delayed
responses in Cabp2LacZ/LacZ compared with Cabp2+/+ animals (P < 0.001, Wilcoxon rank sum test). (D) Variance (б2) of the first-spike latency (scattered against
steady-state firing rate). Variance is increased in SGNs of Cabp2-deficient compared with Cabp2+/+ animals (P < 0.05, Wilcoxon rank sum test).
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pressure levels (50 ms, applied at 5 Hz, 30 dB above threshold at
the characteristic frequency), we found reduced firing rates at
sound onset and after short-term adaptation in Cabp2LacZ/LacZ
SGNs (Fig. 5B). Congruent with the reduction in firing rates, first-
spike latencies were delayed (Fig. 5C; 6.1 ± 0.3 ms vs. 4.9 ± 0.2 ms)
andmore variable (Fig. 5D; variance: 11.5± 3.6 ms2 vs. 6.0± 1.5 ms2)
in Cabp2LacZ/LacZ SGNs. Rate reduction and increased jitter of
SGN firing at sound onset likely explain the impaired ABR wave I
amplitude and threshold.
The reduction in firing rates was also observed when using
500-ms tone bursts (applied at 0.5 Hz; Fig. S6F). Here, adapta-
tion was slightly more pronounced in Cabp2LacZ/LacZ SGNs
(36.4% vs. 20.5% reduction between 40–50 ms and 490–500 ms
after stimulus onset). Interestingly, there was no increase of
spike rate after short-term adaptation as would have been
expected if the excess-sustained exocytosis observed in Cabp2-
deficient IHCs reflected enhanced synaptic release. Therefore, such
excess-sustained exocytosis likely occurs extrasynaptically and does
not contribute to sound encoding, much like the suggested scenario
for mice lacking the EF-hand calcium-binding proteins calbindin–
D-28k, calretinin, and parvalbumin-α (42).
Discussion
Here, we studied the role of CaBP2 in hearing and characterized
the disease mechanism of human sensorineural hearing impair-
ment DFNB93. We identified a DFNB93 mutation that likely
causes a complete loss of CABP2 function. Using constitutive
genetic disruption of Cabp2, we generated a DFNB93 mouse
model that showed a synaptic hearing impairment without loss of
IHCs or their synapses with SGNs. We did not observe obvious
deficits outside the auditory system, which is in keeping with the
rather hair cell-specific expression of CaBP2 and the clinical
findings in DFNB93 (this study and refs. 35, 44). Elevated
thresholds, reduced amplitudes and prolonged latencies of
ABRs, of which the first peak reports the synchronous activation
of SGNs, are likely accounted by the reduced firing rates and
delayed, as well as more variable, spike timing of SGNs at sound
onset. We propose that reduced firing of SGNs in Cabp2LacZ/LacZ
mice results from enhanced steady-state inactivation of CaV1.3 at
the IHC active zone in vivo, reducing the number of Ca2+
channels available for triggering synaptic vesicle release.
Regulation of IHC CaV1.3 Channels by CaBP2. IHC CaV1.3 Ca
2+
channels stand out by reason of their hyperpolarized activation
range and modest inactivation (10, 18, 19, 22, 45). These prop-
erties have been attributed to the molecular composition of the
native Ca2+-channel complexes that, in addition to the specific
pore-forming CaV1.3α1 splice variant (46), auxiliary CaVβ2 (6, 47),
and CaVα2δ2 (7) subunit, also contain interactions partners, such
as Rab3-interacting molecule (RIM) (48, 49); harmonin (50, 51);
calmodulin; and, notably, CaBPs (this study and refs. 18, 19, 34).
CaBPs have been shown to confer both the negative activation
(36) and the noninactivating (18, 19, 35, 52) phenotypes to CaV
channels in HEK293 cells. Our HEK293 cell study demon-
strates that CaBP2 can potently shift CaV1.3 activation to more
hyperpolarized potentials and inhibit CaV1.3 channel inactiva-
tion. Aiming to match the molecular composition of the IHC
CaV1.3 channel complex closely and using coexpression of SK3-1
channels for avoiding potentially toxic Ca2+ influx, we did not
observe the previously reported decrease of Ca2+-current density
upon CABP2 coexpression (35).
Cabp2LacZ/LacZ mice allowed us to confirm expression of
CaBP2 in IHCs and OHCs (18, 34) with high specificity due to
use of a genetic marker. The function of CaBP2 in OHCs re-
mains elusive. Due to the predominant expression of CaV1.3ΔIQ
in OHCs [a splice variant that is lacking the C-terminal CaBP2-
binding isoleucine/glutamine motif (IQ motif) region and CDI
(53)], CaBP2 is probably not required for Ca2+-channel regula-
tion in OHCs. Alternatively, CaBP2 might contribute to Ca2+
buffering also in OHCs. However, quantitative estimates of EF-
hand Ca2+-buffer concentrations proposed 5-mM Ca2+ binding
sites provided by calbindin–D-28k and oncomodulin (31). More-
over, OHC electromotility is critically dependent on oncomodulin
(54), whereas disruption of CaBP2 did not affect cochlear amplifi-
cation. Therefore, CaBP2 likely only plays a minor role in Ca2+
buffering in OHCs.
Using Cabp2LacZ/LacZ mice, we tested the three hypotheses
of CaBP2 action on CaV1.3 channels in IHCs: (i) reducing
Ca2+-current amplitude, (ii) hyperpolarized shift of activation, and
(iii) inhibiting inactivation. Our results could reject the former two
hypotheses: Ca2+-current density in IHCs (i) and voltage dependence
of activation (ii) were unchanged. Ca2+-current inactivation (iii), on
the other hand, was nearly doubled when probing Cabp2-deficient
IHCs of 5-wk-old mice at near-physiological conditions (Fig. 4),
supporting the hypothesis that CaBP2 inhibits the inactivation of
CaV1.3 Ca
2+ channels in IHCs in vivo. We note that Ca2+-current
inactivation was previously shown to be temperature-dependent in
IHCs of rats (16), likely explaining why we observed a smaller
increase of inactivation at room temperature (Fig. S4). There, we
found significantly increased VDI and a nonsignificant trend
toward increased CDI in IHCs of 2- to 3-wk-old Cabp2LacZ/LacZ
mice. A dual role in Ca2+-channel regulation was hypothesized
for CaBP1: The N-lobe/linker regions were suggested to intro-
duce Ca2+-dependent facilitation of CaV1.2 channels, whereas
the C-terminal domains were required for the binding of CaBP1
to the IQ domain and inhibition of CaV1.2 CDI (55, 56). CaBP1
and CaBP2 share the N-terminal myristoylation as a common
modification (27) and, unlike CaBP4 and CaBP5, were impli-
cated in inhibiting VDI of CaV1.3 channels (18), suggesting that
CaBP2 might regulate VDI via the N-lobe region. During VDI,
the alpha interaction domain (AID) of CaV1.3α1 was shown to
play a critical role (57), whereby the “lid” (CaVβ–AID complex)
is thought to mediate VDI by binding segment 6 of CaV1.3α1,
occluding the channel pore (58). Hence, CaBP2 might attenuate
VDI by shielding the Ca2+-channel pore from the CaVβ–AID
complex. Aside from inhibition by CaBP2, CaV1.3 inactivation is
also controlled by the C-terminal regulating domain present or
absent depending on the precise CaV1.3 splice variant (20, 46);
by the CaVβ subunit (6); and by interacting proteins, such as
other CaBPs (18, 19) and RIM (48).
Considering a biological system as complex as the auditory
pathway with limited potential for molecular manipulation, it
seems well-justified to characterize function and regulation of
IHC-like CaV1.3 channels in a “simple” heterologous expression
system, such as HEK293 cells. However, the differences found
here clearly indicate the limitations of a heterologous expression
system to represent the physiology of the native IHC Ca2+ channels,
likely because it has not fully recapitulated the molecular machinery
constituting the presynaptic CaV1.3 Ca
2+-channel complex at the
IHC active zone. Future studies in mice combining CaBP2 dis-
ruption with disruption of CaBP 1, CaBP4, and CaPB5, which are
also expressed in IHCs (18, 19, 34), will be important to compre-
hend the complex regulation of inactivation of IHC Ca2+ channels.
Analysis of Cabp2-Deficient Mice Indicates That DFNB93 Is an
Auditory Synaptopathy. The constitutive disruption of Cabp2 in
mice likely provides an appropriate model for at least some cases
of DFNB93, such as for the newly identified CABP2 mutation,
which probably causes nonsense-mediated decay of Cabp2-
mRNA. Hearing loss characterized by impaired ABR despite
intact cochlear amplification as found in Cabp2LacZ/LacZ mice is
termed “auditory neuropathy” or “auditory synaptopathy,” de-
pending on the site of lesion (40, 59). In keeping with this hy-
pothesis, we observed otoacoustic emissions in one of the DFNB93
subjects described in the present study. As reported for otoferlin-
related synaptopathy, emissions might be lost secondarily (60),














potentially explaining the absence in our previous study (35). Lack
of CaBP2 expression in SGNs and the normal presence of IHCs
and their afferent synapses with SGNs indicated that the hearing
deficit in Cabp2LacZ/LacZ mice resulted from a dysfunction of the
presynaptic active zone. Congruent with previous reports on DFNB93
(35, 44), low to middle frequencies were most affected in human
patients, suggesting that inhibition of Ca2+-current inactivation is
predominantly required for normal perception of low- to middle-
frequency sounds. In fact, in low-frequency hearing animals like
bullfrogs, Ca2+-current inactivation was absent during sine-wave
stimulation, supporting temporally precise glutamate release
and phase-locked excitatory postsynaptic currents (61). Future
genetic manipulation in low-frequency hearing gerbils will be
beneficial for our understanding of how Ca2+-current inactiva-
tion relates to the temporal precision of sound encoding.
In vivo postsynaptic recordings from SGNs revealed reduced
rates of spontaneous and evoked synaptic transmission. Our
analysis of Cabp2-deficient mouse IHCs indicated that the volt-
age dependence of IHC Ca2+ influx was unaltered, ruling out a
mismatch of the operating range of CaV1.3 channels and IHC
receptor potentials, respectively, as a disease mechanism for
DFNB93. These observations leave enhanced CaV1.3 inactiva-
tion as a plausible candidate mechanism for the reduced rates of
transmission at the IHC synapses of Cabp2LacZ/LacZ mice and for
the human hearing impairment DFNB93. The reduction in
spontaneous SGN firing observed in Cabp2LacZ/LacZ mice sug-
gests that some of the CaV1.3 channels are inactivated at the
resting potential upon Cabp2 deficiency, because spontaneous
firing depends on the opening of Ca2+ channels (13). Interestingly,
unlike what is expected from findings in the normal cochlea,
where SGNs with low spontaneous rates tend to display higher
thresholds (43), we found SGNs that combined low spontaneous
rates with low thresholds in Cabp2LacZ/LacZ mice and thresholds
were generally comparable to wild-type SGNs. We argue that
impaired sound coding, also encompassing reduced temporal pre-
cision, characterizes the hearing impairment of human DFNB93
subjects.
We postulate that inactivation within the relatively depolar-
ized operating range of IHCs (11, 12) reduces the number of
synaptic CaV1.3 channels available for stimulus-secretion cou-
pling in the absence of CaBP2. Membrane capacitance (Cm)
measurements turned out to be of limited help for understanding
the effect of CaBP2 disruption on synaptic exocytosis. An en-
hanced spread of the synaptic Ca2+ signal to extrasynaptic re-
lease sites might account for excess sustained vesicle fusion,
which possibly masked a reduction of synaptic exocytosis un-
derlying the reduced SGN spike rates. Based on the normal
sound-evoked firing of SGNs of mice lacking the EF-hand Ca2+
buffers calbindin–D-28k, calretinin, and parvalbumin-α, we as-
sume that the proposed impaired Ca2+ buffering in CaBP2-
deficient IHCs does not contribute to the sound coding deficit in
Cabp2LacZ/LacZ mice. Imaging synaptic Ca2+ signals in CaBP2-
deficient IHCs, as well as studying mice with IHC-specific Cabp2
deletion and virus-mediated rescue of CaBP2 function in IHCs,
will be required to validate the CaV1.3 inactivation hypothesis of
DFNB93 pathophysiology further.
Materials and Methods
Generation of the Cabp2LacZ/LacZ Mouse Line. ES cells carrying the KO allele
were provided by the KOMP repository, and the methods used were pre-
viously described (62). The sequence integrity and the presence of the distal
loxP cassette, together with the correct insertion of the targeted allele, were
confirmed by long-range PCR assay of ES cell clones and subsequent se-
quencing according to the manufacturer’s protocol (Fig. S1 A and B). Primers
used can be found on the KOMP web page. The primer pair to check insertion
of the 3′ target allele is fwd3′ allele and rev3′ allele (primer list is provided in
Table S1). The mutant mice were crossbred with EIIa-cre transgenic mice,
resulting in a global Cabp2 mutant mouse line carrying a LacZ reporter after
exon 2 of Cabp2. Mice of either sex were used at P14–P21, P35–P42, and P49–
P62 for patch-clamping and immunohistochemistry, and at 3–8 wk for systems
physiology. All experiments were performed in compliance with the national
animal care guidelines and were approved by the Board for Animal Welfare of
the University Medical Center Goettingen and the Animal Welfare Office of
the state of Lower Saxony.
RT-PCR. Six organs of Corti were dissected and mRNA-isolated using TRIzol
reagent (Invitrogen) according to the manufacturer’s protocol. For RT, the
GeneAmp RNA PCR Kit (Invitrogen) was applied and purified cDNA of
Cabp2+/+ and Cabp2LacZ/LacZ was amplified by the following primer combi-
nations: PCR-1: forward (fwd) Exon1, reverse (rev) Exon5; PCR-2: fwdLacZ,
revExon5; and PCR-3: fwdGAPDH, revGAPDH (primer list is provided in Table S1).
LacZ Staining. Cochleae and retinae were isolated and fixed for 10min in 0.2%
glutaraldehyde with 5 mM EGTA and 2 mM MgCl2 in 100 mM PB. Tissue was
washed three times for 15 min each time in detergent rinse solution con-
taining 0.02% Igepal, 0.01% 7-deoxycholic acid sodium salt, and 2 mM
MgCl2 in 100 mM PBS (pH 7.3). For the staining reaction, samples were kept
in X-Gal staining solution: 0.02% Igepal, 0.01% 7-deoxycholic acid, 5 mM
K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, and 1 mg/mL X-Gal in 100 mM PBS
(pH 7.3) overnight at 37 °C.
Transient Transfection of HEK 293/hSK3-1 Cells. HEK293/hSK3-1 cells were
maintained in Dulbecco’s modified Eagle medium/F12 Glutamax (GIBCO),
containing 10% (vol/vol) FBS and 400 μg/mL G418 at 37 °C in a humidified
atmosphere with 5% (vol/vol) CO2 saturation. The cells were transfected
with CaV1.3α1 (AF370010, amount: 1×), β2A (BC117468, amount: 0.5×), α2δ1
(NM053851, amount: 0.5×), and CABP2-pEGFP-N1 (AB593136, amount:
0.05x) in ratios according to their length using the transfection reagent
ExGen500 (Biomol) according to the manufacturer’s protocol. The cells were
used for electrophysiological recordings 36–48 h after transfection.
Patch-Clamp Recordings. An EPC-10 amplifier and PatchMaster software
(HEKA) were used for whole-cell patch-clamp recordings utilizing low-pass
filtering at 5 kHz, sampling at 50 kHz, and Rseries compensation of 70% (Rseries
compensation for HEK293 cell experiments only). The external solution for
HEK293 cell recordings contained the following: 150 mM choline Cl, 1 mM
MgCl2, 10 mM Cs-Hepes, 10 mM CaCl2, and 100 nM apamin (pH 7.4 with
methanesulfonic acid and osmolarity of 300–310 mOsm). The internal solu-
tion for HEK293 cell recordings contained the following: 140 mM N-methyl-
D-glucamine, 5 mM EGTA, 10 mM NaCl, 1 mMMgCl2, 10 mM Hepes, and 2 mM
MgATP (pH 7.4, 290 mOsm). Recordings from IHCs were performed in the
perforated- and ruptured-patch configurations. For the perforated-patch
configuration, the pipette solution contained the following: 137 mM Cs-
gluconate, 10 mM tetraethylammonium chloride (TEA-Cl), 10 mM 4-AP,
10 mM Cs-Hepes, 1 mM MgCl2, and 300 μg/mL amphotericin B (pH 7.2, 283
mOsm). For the ruptured-patch configuration, the pipette solution
contained the following: 134 mM Cs-gluconate, 10 mM TEA-Cl, 10 mM 4-AP,
10 mM Cs-Hepes, 1 mM MgCl2, 0.5 mM EGTA, 0.5 mM BAPTA, 0.3 mM
NaGTP, and 2 mM MgATP (pH 7.2, 283 mOsm). The standard bath solution
contained the following: 113 mM NaCl, 35 mM TEA-Cl, 2.8 mM KCl, 1 mM
CsCl, 1 mM MgCl2, mM 10 NaOH-Hepes, 11.3 mM D-glucose, and CaCl2 con-
centrations (pH 7.2, 300–310 mOsm). All patch-clamp experiments were per-
formed at room temperature, except for the recordings in near-physiological
conditions, which also used 1.3 mM [Ca2+]e. Cells were stimulated by depo-
larizations of different durations to −14 mV at intervals of 30–90 s. We mea-
sured and analyzed Cm as previously described (25). Exocytic Cm increments
were analyzed as the difference between Cm during 400 ms before and after
depolarization, skipping the first 100 ms after the end of the depolarizing
pulse. All currents were leak-corrected subtracting the average and scaled
passive current response, which was estimated from the responses to 10 sub-
sequent depolarizations to 10% of the test depolarization and was multiplied
by 10 (P/10). Voltage was corrected for liquid junction potentials calculated by
the Patchers-Power-Tool of Igor-Pro (14 mV for perforated-patch experiments
and 12.2 mV for HEK293/hSK3 recordings).
Systems Physiology: ABRs, Otoacoustic Emissions, and Electroretinography. For
recordings of ABRs and DPOAEs, mice were anesthetized with a combination
of i.p.-administered ketamine (125 mg/kg) and xylazine (2.5 mg/kg). The core
temperature was maintained constant at 37 °C using a heat blanket (Hugo
Sachs Elektronik–Harvard Apparatus). For stimulus generation, presentation,
and data acquisition, we used the TDT II System run by BioSig software
(Tucker Davis Technologies, MathWorks). Tone bursts (4/6/8/12/16/24/32 kHz,
10-ms plateau, 1-ms cos2 rise/fall) or clicks of 0.03 ms were presented at
40 Hz (tone bursts) or 20 Hz (clicks) in the free field ipsilaterally using a JBL
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2402 speaker. The difference potential between vertex and mastoid subdermal
needles was amplified 50,000-fold, filtered (400–4,000 Hz), and sampled at a
rate of 50 kHz for 20 ms for a total of 1,300 times to obtain two mean ABR
traces for each sound intensity. Hearing threshold was determined with 10-dB
precision as the lowest stimulus intensity that evoked a reproducible response
waveform in both traces by visual inspection by two independent observers.
For DPOAE, continuous primary tones (frequency f2 = 1.2 * f1, intensity l2 =
l1–10 dB SPL) were delivered through a MF1 speaker system (Tucker Davis
Technologies) and a custom-made probe containing an MKE-2 microphone
(Sennheiser). The microphone signal was amplified (DMX 6Fire; Terratec), and
the DPOAE amplitude at 2 * f2-f1 was analyzed by fast Fourier transformation
using custom-writtenMATLAB software (MathWorks). SPLs are provided in SPL
root mean square decibels (tonal stimuli) or SPL peak equivalent decibels
(clicks). ERGs were recorded as in the study by tom Dieck et al. (63).
Single Auditory Nerve Fiber Recordings. Single-unit recordings were performed
as described previously (43, 64, 65). In short, mice were anesthetized by i.p.
injection of urethane (1.32 mg/kg), xylazine (5 mg/kg), and buprenorphine
(0.1 mg/kg); tracheostomized; and placed in a stereotactic apparatus. After
partial removal of the occipital bone and cerebellum, the internal auditory
meatus was approached with a glass microelectrode passing through the pos-
terior portion of the cochlear nucleus. Auditory nerve fibers were distinguished
from cochlear nucleus neurons based on their stereotactic position (>1.2 mm
from the surface of the cochlear nucleus, electrode aiming at the internal au-
ditory canal) and response characteristics (poststimulus time histogram, regu-
larity of firing, first-spike latency).
Immunohistochemistry. The apical coil of the organ of Corti was isolated from
P21–P28 or P49–P61 mice and fixed with 4% (vol/vol) paraformaldehyde
in PBS (15 min for synapse stains and 1 h for BK and SK2 staining). For
Ca2+-channel staining, the tissue was fixed in methanol for 20 min at −20 °C.
After incubation of whole-mount preparations for 1 h in goat serum dilution
buffer [16% (vol/vol) normal goat serum, 450 mM NaCl, 0.6% Triton X-100,
20 mM phosphate buffer (pH 7.4)], primary antibodies were applied over-
night at 4 °C. The following antibodies were used: guinea pig anti–parval-
bumin-α (1:200; Synaptic Systems), rabbit anti-BK (1:100; Alomone), mouse
anti–α-calbindin D-28k (1:400; SWANT), rabbit anti-SK2 (1:200; Alomone),
mouse IgG1 anti-CtBP2 (1:200; BD Biosciences, rabbit anti-GluA2/3 (1:200;
Chemicon), and rabbit–anti-CaV1.3 (1:100; Alomone). Secondary AlexaFluor-
labeled antibodies (1:200; Molecular Probes) were applied for 1 h at room
temperature. Confocal images were collected using an SP5 microscope (Leica
Microsystems) and analyzed with ImageJ software (NIH).
For immunostaining of retinal slices, retinae were fixed for 120 min in 4%
(vol/vol) paraformaldehyde in PBS at room temperature, and were sub-
sequently washed in PBS and transferred into sucrose gradient solutions of
10% (wt/vol; 10min, room temperature), 20% (wt/vol; 2 h, room temperature),
and 25% (wt/vol; overnight, 4 °C). After embedding the retina in cryomatrix
(20 min; Life Technology), the tissue was frozen in a cryostat (−25 °C, 2800
Frigocut; Reichert–Jung), sliced (thickness of 60 μm), and stored at −80 °C until
staining. The immunostaining procedure was the same as for the organs of
Corti, just with chicken anti–β-galactosidase (1:100; Abcam) and mouse anti–
α-calbindin D-28k (1:400). For anti–β-galactosidase antibody, a goat anti-chicken
secondary AlexaFluor-labeled antibody (1:200; MoBiTec) was applied.
Protein Purification and Isothermal Titration Calorimetry. His6-tagged CABP2-
wt (wild type) and GST-tagged CABP2-ΔEF3/4 were transformed into
Escherichia coli BL21 (DE3) cells (Merck) and grown at 37 °C. The expression
was induced with 0.5 M isopropyl 1-thio-β-D-galactopyranoside at A600 =
0.6 nm, and the temperature was set to 16 °C. After 15–20 h, the cells were
harvested by centrifugation, resuspended in lysis buffer [20 mM Tris (pH
7.5), 300 mM NaCl, 10% (wt/wt) glycerol], and disrupted using a fluidizer
(Mircofluidics). After centrifugation (45 min, 39086.1 × g), the obtained su-
pernatant of the His6-tagged CABP2-wt protein was loaded onto a nickel-
nitrilotriacetic acid column (GE Healthcare). To elute the protein, an elution
gradient with imidazole-containing buffer [20 mM Tris (pH 7.5), 300 mM NaCl,
10% (vol/vol) glycerol, 500 mM imidazole] was performed, followed by size
exclusion chromatography (S200 16/60; GE Healthcare) [20 mM Tris (pH 7.5),
300 mM NaCl, 10% (vol/vol) glycerol]. The GST-tagged CABP2-ΔEF3/4 protein
was purified using a GST column (GE Healthcare) [20 mM Tris (pH 7.5), 300 mM
NaCl, 10% (vol/vol) glycerol, elution buffer with 20 mM reduced glutathione],
followed by size exclusion chromatography (S200 16/60) [20 mM Tris (pH 7.5),
300 mM NaCl, 10% (wt/wt) glycerol]. Both proteins were incubated with
Chelex (Biorad) to remove remaining Ca2+ ions. During the purification steps,
the temperature was kept at 4 °C.
Isothermal titration calorimetry was performed using a VP-ITC microcal-
orimeter (MicroCal/GE Healthcare). The reference cell was filled with buffer,
and the protein was placed in the sample cell in the same buffer. Each ex-
periment was performed at 8 °C with a protein concentration of 110 μM. The
5 mM CaCl2 solution was prepared in buffer that was also treated with
Chelex. Forty injections of 5 μL were added to the wild-type protein, and 35
injections of 5 μL were added to the mutant. To obtain a baseline after one
injection, a time interval of 210 s was set; the used stirring speed was
307 rpm. Additionally, a titration of CaCl2 in buffer was subtracted from the
data to correct for heat of dilution. Each experiment was repeated three
times. For data analysis and determination of the Kd, ΔH and ΔS values were
measured using MicroCal Origin software running MicroCal/GE Healthcare
ITC analysis routines.
Data Analysis. Voltage of half-maximal Ca2+ current (V0.5) and activation
constant (kact) were calculated by first transforming the current–voltage (I-V)
traces into an activation function: ICa = gmax(V −Vrev), where V describes the
holding potential, Vrev the reversal potential, and gmax the maximum con-
ductance. The activation function was fitted by a Boltzmann function: 1/(1 +
exp((V0.5−V)/kact)). Data were analyzed using Igor Pro Software (Wave-
metrics), Origin (MicroCal), and ImageJ. Means were expressed ± SEM and
compared using two-tailed Student’s t tests for normally distributed data of
equal variance or else by the Wilcoxon rank sum test (if not stated other-
wise), with *P < 0.05, **P < 0.01, and ***P < 0.005, respectively.
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